Claritas Pharmaceuticals Inc V.CLAS.H

Whats the confusion here?

[london4083]

Kalyetra has 2 Programs:
Prevention of GVHD: Which is in Phase 2B(Clinical Study) and as per the website, it wil be complete early next year and then it might go to Phase 3

Treatment of Acute and Chronic GVHD: They have completed Phase 2A and they are planning to move to Phase 2B Clinical Study and they are also planning to do a Phase 2-3 pivotal registration study

Now coming to the SP, it went down because of this ugly financing as they did not have any other option and now it is being controlled at .11 and will definitely move either up or down but hopefully up once they announce that PP is complete. As per my discussion with IR last friday it will be over any day now

Are they delaying Phase 2B ?   Yes but we all are too immature to undestand the reasons 

Does the drug have potential? As per my DD Yes it has but kindly do your own DD

Is KALY the only company making drug for GVHD? No there is another drug in Phase 3 and honestly the management should be questioned in misleading people as they repeatedly say that their drug will be the only drug for treatment of GVHD

Will they be successful in getting FDA Approval? No one knows as only 18% person companies are successful as per data published on google

Is it undervalued at the moment? Yes and SP should atleast be twice of what it is

Do we all want to make money ? Yes

Do all investors make money ? No

As we all have invested our hard earned money in KALY thus I will request all of you to please post meaningful post and share your opinions and let people decide whether they wanna sell or buy

GLTA